Breaking News

OsoBio Appoints Lab Director

By Kristin Brooks | February 24, 2014

Stoker brings 20 years of pharmaceutical quality control experience

Paul W. Stoker, Ph.D., has been appointed director of OsoBio’s chemistry and microbiology laboratories. Dr. Stoker replaces Kathleen Larese, who now serves as director of technical operations.
 
As part of the company’s quality control department, the labs are responsible for testing the in-process and finished products, as well as raw materials and components, for the company’s cGMP sterile manufacturing operations. The labs are also responsible for environmental monitoring and analytical method development.
 
Dr. Stoker brings 20 years of professional experience managing pharmaceutical labs responsible for quality control. Most recently, he served as director of the quality control lab at Dendreon. Prior to that, he directed quality control and analytical laboratories for Nektar Therapeutics.
 
“While continuous quality compliance is key to OsoBio’s business success, it’s even more important to the patients who rely upon the medications we manufacture – and we try to never lose sight of that fact,” said Milton Boyer, president of OsoBio. “Paul will lead a team of scientists who are knowledgeable, capable and highly committed to integrity – delivering excellence to both our clients and the patients we collectively serve.”
 
blog comments powered by Disqus
  • Elemental Impurity Testing

    Elemental Impurity Testing

    Dr. Andrew Fussell, PANalytical ||January 28, 2016
    Advances in elemental impurity testing aid compliance with new USP requirements

  • Heavy Metals in Drug Products

    Heavy Metals in Drug Products

    Nikki Schopp, Team Leader in charge of ICP-MS, ICP-OES and AA testing, SGS||January 29, 2015
    The potential presence of trace amounts of heavy metals in drug products is a real cause for concern with regulators.

  • Microbiological Testing & Contamination Control

    Microbiological Testing & Contamination Control

    Daniel L. Prince, Ph. D., Christopher J. Waskewich, M.S., Kristah J. Kohan, B.S. and Danina G. Rinaldi, B.S. , Gibraltar Laboratories, Inc.||March 7, 2014
    An opinion on the microbial limit test with reference to harmonization.